Amgen IncNASDAQ:AMGN
- LAST PRICE316.9100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots311.1000/ 1
- Ask / Lots321.6800/ 2
- Open / Previous Close--- / 316.9100
- Day Range---
- 52 Week Range
- Volume30
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMGN |
|---|---|---|
| 09:32 ET | 34733 | 318.62 |
| 09:33 ET | 8569 | 319.43 |
| 09:35 ET | 3321 | 319.7399 |
| 09:37 ET | 5344 | 318.46 |
| 09:39 ET | 777 | 318.5548 |
| 09:42 ET | 4644 | 318.11 |
| 09:44 ET | 1780 | 318.99 |
| 09:46 ET | 2608 | 318.49 |
| 09:48 ET | 3269 | 319.095 |
| 09:50 ET | 5398 | 319.1525 |
| 09:51 ET | 800 | 319.23 |
| 09:53 ET | 2068 | 318.595 |
| 09:55 ET | 1613 | 318.72 |
| 09:57 ET | 2100 | 318.92 |
| 10:00 ET | 500 | 319.006 |
| 10:02 ET | 7020 | 319.14 |
| 10:04 ET | 14625 | 319.8754 |
| 10:06 ET | 2467 | 319.64 |
| 10:08 ET | 3703 | 319.86 |
| 10:09 ET | 2293 | 319.37 |
| 10:11 ET | 2940 | 319.62 |
| 10:13 ET | 7397 | 319.62 |
| 10:15 ET | 4843 | 319.87 |
| 10:18 ET | 2234 | 319.82 |
| 10:20 ET | 2628 | 319.705 |
| 10:22 ET | 2819 | 319.8691 |
| 10:24 ET | 2281 | 319.65 |
| 10:26 ET | 6594 | 319.82 |
| 10:27 ET | 2754 | 319.6 |
| 10:29 ET | 1800 | 319.5 |
| 10:31 ET | 1900 | 319.42 |
| 10:33 ET | 1940 | 319.19 |
| 10:36 ET | 2308 | 318.905 |
| 10:38 ET | 3025 | 318.78 |
| 10:40 ET | 2950 | 318.955 |
| 10:42 ET | 2300 | 318.83 |
| 10:44 ET | 1488 | 319.12 |
| 10:45 ET | 900 | 319.13 |
| 10:47 ET | 3888 | 318.5 |
| 10:49 ET | 1364 | 318.785 |
| 10:51 ET | 1105 | 318.7148 |
| 10:54 ET | 200 | 318.68 |
| 10:56 ET | 1527 | 318.805 |
| 10:58 ET | 1000 | 318.75 |
| 11:00 ET | 1818 | 318.29 |
| 11:02 ET | 1454 | 318.265 |
| 11:03 ET | 2273 | 318.47 |
| 11:05 ET | 1274 | 318.31 |
| 11:07 ET | 1262 | 318.215 |
| 11:09 ET | 1311 | 318.375 |
| 11:12 ET | 1838 | 318.595 |
| 11:14 ET | 2339 | 318.538 |
| 11:16 ET | 200 | 318.2739 |
| 11:18 ET | 800 | 318.42 |
| 11:20 ET | 1100 | 318.395 |
| 11:21 ET | 300 | 318.49 |
| 11:23 ET | 1500 | 318.245 |
| 11:25 ET | 10800 | 318.205 |
| 11:27 ET | 1725 | 317.97 |
| 11:30 ET | 8444 | 317.905 |
| 11:32 ET | 2000 | 317.88 |
| 11:34 ET | 1288 | 317.65 |
| 11:36 ET | 1500 | 317.79 |
| 11:38 ET | 904 | 317.76 |
| 11:39 ET | 1636 | 317.43 |
| 11:41 ET | 800 | 317.42 |
| 11:43 ET | 870 | 317.26 |
| 11:45 ET | 2655 | 317.0628 |
| 11:48 ET | 1839 | 316.79 |
| 11:50 ET | 1920 | 316.51 |
| 11:52 ET | 6185 | 316.01 |
| 11:54 ET | 1640 | 316.095 |
| 11:56 ET | 4318 | 315.61 |
| 11:57 ET | 1336 | 315.74 |
| 11:59 ET | 2724 | 315.14 |
| 12:01 ET | 71585 | 314.63 |
| 12:03 ET | 3376 | 315.42 |
| 12:06 ET | 1087 | 315.19 |
| 12:08 ET | 1900 | 315.095 |
| 12:10 ET | 9433 | 315.11 |
| 12:12 ET | 2037 | 314.89 |
| 12:14 ET | 3573 | 315.3 |
| 12:15 ET | 2768 | 315.19 |
| 12:17 ET | 1381 | 315.4815 |
| 12:19 ET | 2295 | 315.5 |
| 12:21 ET | 1200 | 316.18 |
| 12:24 ET | 2800 | 316.305 |
| 12:26 ET | 819 | 316.59 |
| 12:28 ET | 10662 | 316.89 |
| 12:30 ET | 400 | 317 |
| 12:32 ET | 4602 | 316.82 |
| 12:33 ET | 2900 | 316.6625 |
| 12:35 ET | 1150 | 316.69 |
| 12:37 ET | 4158 | 316.815 |
| 12:39 ET | 2477 | 316.9099 |
| 12:42 ET | 600 | 316.78 |
| 12:44 ET | 1358 | 316.72 |
| 12:46 ET | 500 | 316.55 |
| 12:48 ET | 1000 | 316.63 |
| 12:50 ET | 1298 | 316.435 |
| 12:51 ET | 775 | 316.66 |
| 12:53 ET | 1280 | 316.79 |
| 12:55 ET | 1300 | 316.83 |
| 12:57 ET | 600 | 316.57 |
| 01:00 ET | 375 | 316.577 |
| 01:02 ET | 1416 | 316.82 |
| 01:04 ET | 1441 | 316.7 |
| 01:06 ET | 1918 | 316.67 |
| 01:08 ET | 6276 | 316.815 |
| 01:09 ET | 7380 | 316.745 |
| 01:11 ET | 800 | 317.11 |
| 01:13 ET | 2023 | 317.375 |
| 01:15 ET | 5636 | 317.195 |
| 01:18 ET | 100 | 317.24 |
| 01:20 ET | 748 | 317.29 |
| 01:22 ET | 1124 | 317.25 |
| 01:24 ET | 500 | 317.3 |
| 01:26 ET | 433 | 317.3 |
| 01:27 ET | 500 | 317.4 |
| 01:29 ET | 2807 | 317.16 |
| 01:31 ET | 3493 | 317.2 |
| 01:36 ET | 700 | 317.215 |
| 01:38 ET | 1002 | 317.1744 |
| 01:40 ET | 1411 | 317.155 |
| 01:42 ET | 300 | 317.08 |
| 01:44 ET | 3276 | 317.34 |
| 01:45 ET | 1135 | 317.335 |
| 01:47 ET | 922 | 317.4584 |
| 01:49 ET | 12657 | 317.725 |
| 01:51 ET | 3631 | 317.61 |
| 01:54 ET | 1800 | 317.64 |
| 01:56 ET | 800 | 317.56 |
| 01:58 ET | 1199 | 317.725 |
| 02:00 ET | 500 | 317.79 |
| 02:02 ET | 685 | 317.65 |
| 02:03 ET | 700 | 317.655 |
| 02:05 ET | 2982 | 317.625 |
| 02:07 ET | 1234 | 317.6501 |
| 02:09 ET | 900 | 317.63 |
| 02:12 ET | 2837 | 317.54 |
| 02:14 ET | 7507 | 317.43 |
| 02:16 ET | 1354 | 317.245 |
| 02:18 ET | 1700 | 317.345 |
| 02:20 ET | 800 | 317.25 |
| 02:23 ET | 919 | 317.24 |
| 02:25 ET | 2779 | 316.92 |
| 02:27 ET | 1208 | 316.84 |
| 02:30 ET | 2919 | 316.79 |
| 02:32 ET | 2213 | 316.47 |
| 02:34 ET | 2014 | 316.55 |
| 02:36 ET | 1600 | 316.55 |
| 02:38 ET | 3568 | 316.4099 |
| 02:39 ET | 651 | 316.22 |
| 02:41 ET | 6374 | 316.08 |
| 02:43 ET | 400 | 315.995 |
| 02:45 ET | 1610 | 315.6801 |
| 02:48 ET | 2324 | 315.75 |
| 02:50 ET | 3682 | 315.7181 |
| 02:52 ET | 1270 | 315.895 |
| 02:54 ET | 504 | 316.025 |
| 02:56 ET | 1482 | 315.83 |
| 02:57 ET | 801 | 316.115 |
| 02:59 ET | 1130 | 316.18 |
| 03:01 ET | 1905 | 315.925 |
| 03:06 ET | 543 | 315.91 |
| 03:08 ET | 900 | 315.975 |
| 03:10 ET | 1500 | 315.92 |
| 03:12 ET | 950 | 315.82 |
| 03:14 ET | 1917 | 315.9 |
| 03:15 ET | 609 | 315.93 |
| 03:17 ET | 712 | 315.91 |
| 03:19 ET | 1970 | 315.94 |
| 03:21 ET | 2511 | 316.27 |
| 03:24 ET | 2518 | 316.3199 |
| 03:26 ET | 1045 | 316.41 |
| 03:28 ET | 912 | 316.5 |
| 03:30 ET | 2069 | 316.4 |
| 03:32 ET | 627 | 316.73 |
| 03:33 ET | 4453 | 316.57 |
| 03:35 ET | 4205 | 316.72 |
| 03:37 ET | 1897 | 316.705 |
| 03:39 ET | 1000 | 316.66 |
| 03:42 ET | 2790 | 316.97 |
| 03:44 ET | 1042 | 317.075 |
| 03:46 ET | 1312 | 317.13 |
| 03:48 ET | 2371 | 316.92 |
| 03:50 ET | 2491 | 316.72 |
| 03:51 ET | 7644 | 316.95 |
| 03:53 ET | 10246 | 316.87 |
| 03:55 ET | 17884 | 317.13 |
| 03:57 ET | 20241 | 316.71 |
| 04:00 ET | 544218 | 316.91 |
Yesterday
DJ Big Pharma's Obesity Bonanza Faces New Tests -- Heard on the Street -- WSJ, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ Amgen Is Maintained at Neutral by UBS, from 3:47PM ET on Thursday Oct 31, 2024 by Dow Jones
3:47PM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
DJ Amgen Posts Higher 3Q Sales on Strong Demand, from 4:03PM ET on Wednesday Oct 30, 2024 by Dow Jones
4:03PM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ Amgen 3Q Worldwide Prolia Sales $1.05B >AMGN, from 4:02PM ET on Wednesday Oct 30, 2024 by Dow Jones
4:02PM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ Amgen 3Q EPS $5.22 >AMGN, from 4:01PM ET on Wednesday Oct 30, 2024 by Dow Jones
4:01PM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amgen Inc | 170.3B | 40.6x | -0.22% |
Gilead Sciences Inc | 111.9B | 109.7x | +1.53% |
AstraZeneca PLC | 221.3B | 34.6x | +17.52% |
Bristol-Myers Squibb Co | 112.4B | -15.4x | +4.90% |
Haleon PLC | 43.5B | 17.9x | --- |
Sanofi SA | 134.3B | 27.1x | +4.55% |
Company Information
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
Contact Information
- Headquarters
- One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
- Phone
- 805-447-1000
- Fax
- 805-447-1010
Executives
- Chairman of the Board, President, Chief Executive Officer
- Robert Bradway
- Chief Financial Officer, Executive Vice President
- Peter Griffith
- Executive Vice President, Chief Technology Officer
- David Reese
- Executive Vice President, Research and Development, and Chief Scientific Officer
- James Bradner
- Executive Vice President, General Counsel, Secretary
- Jonathan Graham
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $170.3B |
|---|---|
Revenue (TTM) | $32.5B |
Shares Outstanding | 537.5M |
Dividend Yield | 2.84% |
Annual Dividend Rate | 9.0000 USD |
Ex-Dividend Date | 11-18-24 |
Pay Date | 12-09-24 |
Beta | 0.59 |
EPS | $7.82 |
Book Value | $11.64 |
P/E Ratio | 40.6x |
Price/Sales (TTM) | 5.2 |
Price/Cash Flow (TTM) | 17.4x |
Operating Margin | 19.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
